Close Search
JDDonline - Journal of Drugs in Dermatology
  • Home
  • Issues
    • Current Issue
    • eJDD
    • Featured Articles
    • Archived Issues
    • Supplement Library
    • Case Reports
    • Unlocked Access
    • JDD Corner
    • Clinical Solutions
  • Topics
    • Atopic Dermatitis
    • Oats in Skincare
    • Oncoderm
    • Pigmentary Disorders
    • Psoriasis
    • Inclusive Dermatology Atlas
    • Social and Technology
    • Latest News
  • CME
    • CME Activities
  • Multimedia
    • JDD Corner
    • Video Abstracts
    • Podcast
    • Webinars
    • Translational Lecture Series
    • Video Pearls
  • Info
    • About JDD
    • Advertisers
      • Media Kit
      • Podcast Sponsorship
      • Reprints Contact Us
    • Authors
      • Instructions to Authors
      • Submit a Manuscript
      • Author and Peer Review Login
    • Editorial Board
    • Events
    • Contact Editorial
    • Why Publish in the JDD?
    • Institutional, Library, & Corporate Subscriptions
    • Reprints Contact Us
    • SanovaWorks
  • Inclusive Derm Atlas
    • Online Gallery
    • Digital Edition
  • Subscribe Now
  • Log In
  • x-twitter facebook linkedin instagram
May 26
Love0

Predicting Benefit of Adjuvant Radiation Therapy for Cutaneous Squamous Cell Carcinoma: A Systematic Review

By Chuck Lin No Comments
INTRODUCTIONCutaneous squamous cell carcinoma (cSCC) is the second most prevalent skin cancer, and its incidence is rising.1,2 The majority of cSCC are cured by surgical interventions (ie, wide local excision…
Read More
May 26
Love0

A Review of the Relationship Between Cutibacterium acnes, Biofilms, and Keratosis Pilaris

By Chuck Lin No Comments
INTRODUCTIONKeratosis pilaris (KP) is a very common, benign dermatological disorder with characteristic small keratotic papules in a folliculocentric pattern.1 This paper aims to explore the relationship between KP and Cutibacterium…
Read More
May 26
Love0

Perioperative Use of Angiotensin Inhibitors and Their Complications in Mohs Surgery: A Retrospective Cohort Study

By Chuck Lin No Comments
INTRODUCTIONAngiotensin-converting enzyme inhibitors (ACEis) and angiotensin receptor blockers (ARBs) are among the most commonly prescribed antihypertensives worldwide.1 While these agents are effective in managing hypertension, recent studies suggest that modulation…
Read More
May 19
Love0

Treating Acne Vulgaris and Scarring With Botulinum Toxin: A Systematic Review

By Chuck Lin No Comments
INTRODUCTIONAcne vulgaris is a debilitating disease involving the sebaceous glands and the proliferation of Propionibacterium acnes (P. acnes). This skin condition is highly prevalent in the adolescent population, affecting over…
Read More
May 18
Love0

Treatment of Seborrheic Dermatitis and Post-Inflammatory Hypopigmentation With Roflumilast Foam in Skin of Color Patients

By Chuck Lin No Comments
INTRODUCTIONSeborrheic dermatitis (SD) is a common, chronic, and relapsing inflammatory skin disorder. It is characterized by pruritic, erythematous plaques with overlying greasy scale, typically distributed in areas rich in sebaceous…
Read More
May 18
Love0

Resolution of Hand, Foot, and Mouth Disease With Valacyclovir

By Chuck Lin No Comments
INTRODUCTION Hand, foot, and mouth disease (HFMD) is a contagious viral infection most commonly caused by Coxsackievirus A16 (CVA16) and Enterovirus A71 (EVA71), members of the Enterovirus genus within the…
Read More
May 15
Love0

Dual Therapy for Atopic Dermatitis: Lebrikizumab and JAK inhibitors used in Tandem for Treatment-Resistant Cases

By Chuck Lin No Comments
INTRODUCTION Atopic dermatitis (AD) is an inflammatory skin disease marked by intense pruritus, impaired skin barrier function, and recurrent flares.1 Its prevalence in the United States is estimated to range…
Read More
May 14
Love0

Formulary Coverage of Topical Rosacea Therapies in United States Commercial Insurance: A Cross-Sectional Review

By Chuck Lin No Comments
To the Editor, Rosacea is a chronic inflammatory disorder primarily affecting the face, characterized by erythema, telangiectasia, inflammatory lesions, and flushing.1 Rosacea affects up to 10% of the global population…
Read More
Apr 30
Love1

Longer Pembrolizumab Therapy Reduces Mortality in Stage III and IV Melanoma: A TriNetX Study

By Chuck Lin No Comments
INTRODUCTIONMelanoma is the leading cause of skin cancer-related mortality worldwide.¹ Advances in anti-programmed cell death protein 1 (PD-1) therapies, such as pembrolizumab, have significantly improved survival outcomes in advanced melanoma.²…
Read More
Apr 30
Love1

Efficacy and Safety of Topical Metformin vs Kligman Formula in the Treatment of Melasma: A Split-Face Study

By Chuck Lin No Comments
INTRODUCTIONMelasma is a frequent chronic pigmentary condition that is resistant to treatment, most commonly affecting Fitzpatrick skin types III to V.1 Worldwide, melasma is one of the most prevalent dermatoses,…
Read More
Apr 30
Love1

Safety and Efficacy of Aminolevulinic Acid 20% Topical Solution Activated by Blue Light for Facial Cutaneous Squamous Cell Carcinoma in situ

By Chuck Lin No Comments
INTRODUCTIONNonmelanoma skin cancer is the most common form of cancer, with cutaneous squamous cell carcinoma (SCC) accounting for more than 20% of all skin cancers.1,2 Although historically less prevalent than…
Read More
Apr 30
Love1

Advances in Gentle Polymeric Cleansing Technologies

By Chuck Lin No Comments
INTRODUCTIONThe primary goal of a skin cleanser is to remove surface dirt, sweat, sebum, and contaminants without irritating or drying the skin. The key ingredients in cleansers include surfactants for…
Read More
« Previous
NextPrevious »

Search page

Advertisement

Popular

  • Hair Loss Awareness Month August 7, 2026
  • “Please sir, I want some more:” When Rescue Becomes Routine With Prednisone in IBD Care August 7, 2026
  • “Please sir, I want some more:” When Rescue Becomes Routine With Prednisone in IBD Care August 7, 2026
  • Photoprotection 2026: Clinical Updates, Global Trends, and the US Regulatory Evolution August 6, 2026
  • GLP-1 Receptor Agonist Use for Diabetes Mellitus is Associated With Reduced Psoriasis Disease Severity August 6, 2026

Advertisement

News Topics

  • Inclusive Derm Atlas
  • Atopic Dermatitis
  • CME
  • Featured Articles
  • Issue Highlights
  • Oats in Skincare
  • Oncoderm
  • Pigmentary Disorders
  • Psoriasis
  • Skin of Color
CONTACT US     |      FEEDBACK    |      TERMS     |      COOKIE POLICY    |     PRIVACY    |      EDITORIAL POLICY    |     ADVERTISING POLICY  |    MANAGE PREFERENCES  |  YOUR PRIVACY CHOICES

News Topics

  • Inclusive Derm Atlas
  • Atopic Dermatitis
  • CME
  • Featured Articles
  • Issue Highlights
  • Oats in Skincare
  • Oncoderm
  • Pigmentary Disorders
  • Psoriasis
  • Skin of Color
DermAtlas        Derm In-Review         PDE        Next Steps in Derm         Skin of Color Update     ODAC Dermatology, Aesthetic & Surgical Conference LVD        PDE       

Journal of Drugs in Dermatology

  • About Us
  • Contact Us
  • Contact Sales
  • Editorial Board
  • eJDD
  • Institutional, Library, & Corporate Subscriptions
  • Log In
  • Open Access
  • Permissions Request
  • Podcast Sponsorship
  • Subscription Info
  • Store

© 2026 Journal of Drugs in Dermatology. All Rights Reserved. JDD, a peer-reviewed, MEDLINE®/PubMed® indexed journal, offers the dermatology community strong content of utmost quality and relevance on drugs, devices, and methods.

  • twitter
  • facebook
  • linkedin
  • instagram
Close Menu
  • Home
  • Issues
    • Current Issue
    • eJDD
    • Featured Articles
    • Archived Issues
    • Supplement Library
    • Case Reports
    • Unlocked Access
    • JDD Corner
    • Clinical Solutions
  • Topics
    • Atopic Dermatitis
    • Oats in Skincare
    • Oncoderm
    • Pigmentary Disorders
    • Psoriasis
    • Inclusive Dermatology Atlas
    • Social and Technology
    • Latest News
  • CME
    • CME Activities
  • Multimedia
    • JDD Corner
    • Video Abstracts
    • Podcast
    • Webinars
    • Translational Lecture Series
    • Video Pearls
  • Info
    • About JDD
    • Advertisers
      • Media Kit
      • Podcast Sponsorship
      • Reprints Contact Us
    • Authors
      • Instructions to Authors
      • Submit a Manuscript
      • Author and Peer Review Login
    • Editorial Board
    • Events
    • Contact Editorial
    • Why Publish in the JDD?
    • Institutional, Library, & Corporate Subscriptions
    • Reprints Contact Us
    • SanovaWorks
  • Inclusive Derm Atlas
    • Online Gallery
    • Digital Edition
  • Subscribe Now
  • Log In

Search

  • x-twitter
  • facebook
  • linkedin
  • instagram